← Back to Search

Strong Minds for Mental Health

Waitlist Available
Led By Margarita Alegria, Ph.D.
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Adult 18+
Moderate to severe depressive or anxiety symptoms
Screening 3 weeks
Treatment Varies
Follow Up baseline, 3 months, 6 months, and 12 months after baseline
Awards & highlights
No Placebo-Only Group

Study Summary

This trial will test the effectiveness of the STRONG MINDS model to improve engagement and quality of treatment for depression and anxiety among low-income racial/ethnic and linguistic minority populations, served by Medicaid ACOs in North Carolina (NC) and Massachusetts (MA).

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 3 months, 6 months, and 12 months after baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 3 months, 6 months, and 12 months after baseline for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Engagement in MH (change)
Functioning: WHODAS 2.0 (change)
Hopkins Symptoms Checklist-25 (change)
+1 more
Secondary outcome measures
CAT-MH (including CAT-SA for substance) (change)

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Strong Minds ProgramExperimental Treatment1 Intervention
This is a 10-session, culturally-adapted intervention, that includes cognitive behavioral therapy techniques combined with mindfulness exercises, led by a Community Health Worker.
Group II: Enhanced Usual CareExperimental Treatment1 Intervention
Enhanced usual care includes check in calls by a Care Manager 4 times over the course of 6 months and educational materials about depression and anxiety.
First Studied
Drug Approval Stage
How many patients have taken this drug
Strong Minds

Find a Location

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor
2,896 Previous Clinical Trials
13,173,942 Total Patients Enrolled
1 Trials studying Mental Health
1,020 Patients Enrolled for Mental Health
University of North Carolina, GreensboroOTHER
30 Previous Clinical Trials
15,547 Total Patients Enrolled
1 Trials studying Mental Health
18 Patients Enrolled for Mental Health
Margarita Alegria, Ph.D.Principal Investigator - Massachusetts General Hospital
Massachusetts General Hospital
3 Previous Clinical Trials
1,098 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment currently open in this clinical trial?

"As verified on clinicaltrials.gov, enrollment for this research is ongoing and has been active since August 30th 2019. The most recent edit to the page was made on April 4th 2022."

Answered by AI

To what extent has the recruitment for this clinical trial been successful?

"Affirmative. Cited on clinicaltrials.gov, this medical trial has been actively recruiting since 8/30/2019 and was last updated on 4/4/2022. The recruitment of 1200 patients from 2 sites is the primary goal of this research initiative."

Answered by AI
~193 spots leftby Feb 2025